Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Arda Guler's new era: Mourinho's planKeyBanc lowers Karman Holdings stock price targetPashinyan to separatists: 'I will uproot you all'KeyBanc Raises CryoPort Target to $17 on GrowthKeyBanc Maintains Alphabet Rating on AI GrowthNumber of female deputy mayors increasesData I/O Q1 Earnings Miss Amid Strategic ShiftsAli Asadov Opens Railway Border with GeorgiaAEP Plantations Monitors Indonesia CPO Export ProposalBioStem Misses Q1 2026 Earnings, Stock Drops 14.88%Arda Guler's new era: Mourinho's planKeyBanc lowers Karman Holdings stock price targetPashinyan to separatists: 'I will uproot you all'KeyBanc Raises CryoPort Target to $17 on GrowthKeyBanc Maintains Alphabet Rating on AI GrowthNumber of female deputy mayors increasesData I/O Q1 Earnings Miss Amid Strategic ShiftsAli Asadov Opens Railway Border with GeorgiaAEP Plantations Monitors Indonesia CPO Export ProposalBioStem Misses Q1 2026 Earnings, Stock Drops 14.88%
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU
ANALYST RATINGS

Raymond James Keeps Market Perform on CAVA

Raymond James maintains Market Perform rating on CAVA after impressive Q1 earnings with 9.7% comp sales growth and raised guidance.

James Taylor
ByJames Taylor- Senior Editor
|
0
Raymond James Keeps Market Perform on CAVA
Photo: Prepared by Bond.az

Bond.az - Raymond James reiterated its Market Perform rating on CAVA Group Inc (NYSE:CAVA) following strong Q1 results.

The Mediterranean chain reported 9.7% comparable sales growth, including 6.8% traffic growth.

The firm noted a strong reacceleration after modest results in H2 2025.

CAVA raised its 2026 guidance to 4.5%-6.5% comparable sales growth.

Shares trade at about 49x 2026 EV/EBITDA, reflecting high valuation.

More News
KeyBanc lowers Karman Holdings stock price target
Today / 11:03
|
790

KeyBanc lowers Karman Holdings stock price target

KeyBanc lowered Karman Holdings price target to $100 from $122. Shares down 46% from highs. Analysts cut earnings forecasts.

ANALYST RATINGS →
0
KeyBanc Raises CryoPort Target to $17 on Growth
Today / 11:02
|
234

KeyBanc Raises CryoPort Target to $17 on Growth

KeyBanc raises CryoPort price target to $17, citing revenue visibility and expanding margins. Overweight rating maintained.

ANALYST RATINGS →
0
KeyBanc Maintains Alphabet Rating on AI Growth
Today / 11:01
|
578

KeyBanc Maintains Alphabet Rating on AI Growth

KeyBanc maintains Overweight rating on Alphabet stock with $425 target, citing AI growth and product transformation. PEG ratio of 0.63 indicates reasonable valuation.

ANALYST RATINGS →
0
Citizens Upgrades Toll Brothers Rating on Strong Earnings
Today / 10:40
|
600

Citizens Upgrades Toll Brothers Rating on Strong Earnings

Citizens upgrades Toll Brothers rating after strong Q2 earnings beat, highlighting price and volume performance.

ANALYST RATINGS →
0
Stifel Raises Palo Alto Networks Target to $275
Today / 10:13
|
825

Stifel Raises Palo Alto Networks Target to $275

Stifel raises Palo Alto Networks price target to $275 amid strong demand and positive partner checks. Stock near 52-week high.

ANALYST RATINGS →
0
Morgan Stanley hikes CAVA price target
Today / 10:03
|
326

Morgan Stanley hikes CAVA price target

Morgan Stanley raises CAVA price target to $86 on strong sales trends. Equalweight rating maintained despite valuation concerns.

ANALYST RATINGS →
0
Stifel raises Cava Group price target to $105
Today / 10:02
|
685

Stifel raises Cava Group price target to $105

Stifel raises Cava Group price target to $105, citing strong comps and AI investments. Analysts remain bullish on growth.

ANALYST RATINGS →
0
Jefferies Raises Cava Target to $95 on Strong Sales
Today / 10:01
|
779

Jefferies Raises Cava Target to $95 on Strong Sales

Jefferies raises Cava Group price target to $95 from $85, citing strong same-store sales growth and positive momentum. Maintains Buy rating.

ANALYST RATINGS →
0
Citizens Raises Rithm Capital Price Target
Today / 09:01
|
899

Citizens Raises Rithm Capital Price Target

Citizens raises Rithm Capital price target to $13.50, highlighting asset growth and a shift to asset management. RITM offers a 11.11% dividend yield.

ANALYST RATINGS →
0
Citizens Raises Relay Price Target to $21
Today / 09:00
|
268

Citizens Raises Relay Price Target to $21

Citizens raises Relay Therapeutics price target to $21 on strong trial data for zovegalisib, with shares up 296%.

ANALYST RATINGS →
0
Raymond James Upgrades SM Energy on Oil Strength
Today / 08:32
|
341

Raymond James Upgrades SM Energy on Oil Strength

Raymond James upgrades SM Energy to Outperform with $55 target on oil strength. SM Energy benefits from Iran war oil price surge.

ANALYST RATINGS →
0
Jefferies Initiates SAB Biotherapeutics with Buy
Today / 08:21
|
408

Jefferies Initiates SAB Biotherapeutics with Buy

Jefferies initiates coverage on SAB Biotherapeutics with a Buy rating and $11 target, focusing on SAB-142 diabetes therapy.

ANALYST RATINGS →
0
...